FRANKFURT, March 9 (Reuters) - Roche's shares dropped more than 5% on Monday as the Swiss drugmaker failed to show that its ...

Roche said the late-stage trial did not provide reliable evidence that ​the drug's use in combination with Pfizer's Ibrance ...

By Sneha S K March 9 (Reuters) - Bristol Myers Squibb on Monday said its experimental drug for a rare form of blood cancer ...

The content creator, 26, was diagnosed with a rare bile duct cancer nearly three years ago ...

FRANKFURT, March 9 (Reuters) - Shares in Roche dropped more than 5% on Monday as the Swiss drugmaker failed to show that its ...

Surgeon Gareth Honeybone wants wider access to zanidatamab to treat one of the deadliest cancers.

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

A man who shipped counterfeit cancer drugs to Houston was sentenced to 43 months in federal prison after pleading guilty to ...

The drug is sometimes prescribed to certain at-risk people—but what does the science say?

Cancer treatment in India costs 3x more than average ailments. These duty cuts on medicines help reduce out-of-pocket costs in public and private hospitals.

Neuroscientists at King's College London have pinpointed a mechanism behind the increased neural connectivity observed in the very early stages of Alzheimer's disease. Published in Translational ...

The cancer drug tazemetostat (Tazverik) is being voluntarily withdrawn in the U.S. and all other markets over concerns about secondary cancers, drugmaker Ipsen announced. The company also said it is ...